Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease.

Hospital de Clinicas de Porto Alegre1 site in 1 country74 target enrollmentJanuary 2007

ConditionsCoronary Heart Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronary Heart Disease
Sponsor: Hospital de Clinicas de Porto Alegre
Enrollment: 74
Locations: 1
Primary Endpoint: Reduction of Predicted Cardiovascular Risk
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Evaluate the impact of systematic nursing orientations in the reduction of predicted cardiovascular risk in patients with coronary artery disease during four nursing visits for a 1-year period and compare to a group of patients submitted to conventional treatment.

Detailed Description

Assess 184 (two groups) patients during four nursing visits for a 1-year period and compare to a group of patients submitted to conventional treatment. We will evaluate the impact of systematic nursing orientations in the reduction of predicted cardiovascular risk in patients with coronary artery disease.

Registry

clinicaltrials.gov

Start Date

January 2007

End Date

July 2011

Last Updated

13 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Hospital de Clinicas de Porto Alegre

Responsible Party

Principal Investigator

Eneida Rejane Rabelo da Silva

Professor, PhD.

Hospital de Clinicas de Porto Alegre

Eligibility Criteria

Inclusion Criteria

•patients of both sexes;
•aged 18 years or older;
•diagnosed with ACS (unstable angina and acute myocardial infarction with ST segment elevation and without ST segment elevation) with CAD diagnosed by cardiac catheterization or electrocardiogram;
•patients have to agree to participate by signing a consent term

Exclusion Criteria

•patients with cognitive deficits;
•neurological sequelae;
•who are not able to come for visits, or who do not consent to participate in the study.

Outcomes

Primary Outcomes

Reduction of Predicted Cardiovascular Risk

Time Frame: one year

Secondary Outcomes

Knowledge of the risk factors and the adhesion to pharmacology treatment; Reduction of the modified risk factors in the previous knowledge of patients and their adhesion;(one year)